Literature DB >> 178833

Experimental panencephalitis induced in suckling mice by parainfluenza type 1 (6/94) virus. I. Clinical and pathological features.

L B Rorke, K H Gilden, Z Wroblewska, J S Wolinsky.   

Abstract

Intracerebral inoculation of two strains of suckling mice with 6/94 virus, a parainfluenza type 1 virus originally isolated from two patients with multiple sclerosis, produced clinical disease 1-2 weeks after inoculation. Of 528 animals inoculated, 33% died (26% of the ICR strain and 76% of the BALB/c strain) usually between two or three weeks after injection. Animals that recovered appeared to develop normally. Pathological changes were of two types. Initially, there was a necrotizing panencephalitis with virus-specific intracytoplasmic inclusions in choroid and ependymal epithelial cells and neurons. The second major lesion appeared about 6 weeks post inoculation and consisted of a noninflammatory spongiform degeneration of white matter that primarily involved the cerebral hemispheres; a diffuse vacuolar encephalapathy primarily affecting the brain stem; and a persistent minimal inflammation.

Entities:  

Mesh:

Year:  1976        PMID: 178833     DOI: 10.1097/00005072-197605000-00003

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  3 in total

1.  Pathological alterations of ependyma and choroid plexus after experimental cerebral infection of mice with Sendai virus.

Authors:  G Schwendemann; J Löhler
Journal:  Acta Neuropathol       Date:  1979-04-12       Impact factor: 17.088

2.  Experimental infection of human leukocytes with parainfluenza 1 (6/94) virus.

Authors:  C Bogen; D H Gilden; Z Wroblewska; J S Wolinsky
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

3.  Subacute sclerosing panencephalitis in an infant: diagnostic role of viral genome analysis.

Authors:  T Z Baram; I Gonzalez-Gomez; Z D Xie; D Yao; F H Gilles; M D Nelson; H T Nguyen; J Peters
Journal:  Ann Neurol       Date:  1994-07       Impact factor: 10.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.